Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients

No abstract

Bibliographic Details
Main Author:	Abdorreza Naser Moghadasi
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2021-07-01
Series:	Iranian Journal of Public Health
Online Access:	https://ijph.tums.ac.ir/index.php/ijph/article/view/16252

Similar Items

Fampridine Therapy in Multiple Sclerosis: We Should Think Twice
by: Mohamed S A Mohamed
Published: (2018-03-01)

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
by: Francisco Alejandro Rodriguez-Leal, et al.
Published: (2019-04-01)

Multiple sclerosis in parsis: a historical issue.
by: Abdorreza Naser Moghadasi
Published: (2014-03-01)

Kissing Lesion: Atypical Cortical Involvement in a Patient With Relapsing-Remitting Multiple Sclerosis: Clinical Image
by: Abdorreza Naser Moghadasi
Published: (2020-11-01)

Radiological Presentation of a Patient With Multiple Sclerosis and Hepatic Disorder
by: Saeideh Salehizadeh, et al.
Published: (2020-04-01)

Development, and evaluation of drug monitoring system for multiple sclerosis patients
by: Reza Safdari, et al.
Published: (2021-01-01)

A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis
by: L. Ramió-Torrentà, et al.
Published: (2018-06-01)

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
by: Tjalf Ziemssen, et al.
Published: (2017-03-01)

Assessment of the efficacy and safety of fampridine
by: Beatriz Mejuto, et al.
Published: (2017-03-01)

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting
by: Philipp Albrecht, et al.
Published: (2018-10-01)

Bladder Dysfunction in Iranian Patients with Multiple Sclerosis
by: Azadvari M, et al.
Published: (2020-04-01)

A Smartphone-based Application for Self-Management in Multiple Sclerosis
by: Mahdieh Mokhberdezfuli, et al.
Published: (2021-01-01)

Do Multiple Sclerosis and Neuromyelitis Optica Patients Have a Lower Chance of Developing Neurological Complications of COVID-19, Compared to Healthy People? The Role of ACE2
by: Abdorreza Naser Moghadasi, et al.
Published: (2020-05-01)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
by: Mahsa Arzani, et al.
Published: (2018-01-01)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
by: Nasim Rezaeimanesh, et al.
Published: (2020-04-01)

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
by: Mohammad Ali Sahraian, et al.
Published: (2020-05-01)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
by: Mahsa Ghajarzadeh, et al.
Published: (2014-11-01)

Contentment Drug: An Ancient Persian Text about Happiness
by: Abdorreza Naser Moghadasi
Published: (2014-08-01)

Validity and reliability of Persian version of activities-specific balance confidence scale in patients with multiple sclerosis
by: Homa Zarrinkoob, et al.
Published: (2017-05-01)

The Possible Direct Correlation between Cognitive Impairment and Fear of Catching COVID-19 among Patients with Multiple Sclerosis
by: Roghayyeh Saeedi, et al.
Published: (2021-06-01)

Improvement of walking ability in patients with adrenoleukodystrophy treated with fampridine as compassionate use
by: M.I. Morales-Casado, et al.
Published: (2021-06-01)

Redox Imbalance in CD4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients
by: Mohammad Javad Tavassolifar, et al.
Published: (2020-01-01)

Symptomatic therapy in multiple sclerosis
by: Teresa C. Frohman, et al.
Published: (2011-03-01)

The symptomatic management of multiple sclerosis
by: Schapiro Randall
Published: (2009-01-01)

Symptomatic management in multiple sclerosis
by: Pushkar Shah
Published: (2015-01-01)

Determination of Minimum Data Set for Designing a Diagnosis Decision Support System and Medication Follow-Up for Multiple Sclerosis
by: Sahar Khenarinezhad, et al.
Published: (2020-04-01)

HPLC method development for fampridine using Analytical Quality by Design approach
by: Kovács Béla, et al.
Published: (2020-12-01)

A Sample of a Mytho-pathologic Study:The Story of Rostam and Esfandiyar
by: Abdorreza Naser Moghadasi
Published: (2014-11-01)

Agnosia in Canon: a Historical Issue.
by: Abdorreza Naser Moghadasi
Published: (2014-06-01)

First Skull Surgery in Iran: The Burned City and a 4800-Year-Old Skull.
by: Abdorreza Naser Moghadasi
Published: (2014-02-01)

Seizure in Iranian patients with multiple sclerosis
by: Mohammad Zare, et al.
Published: (2013-01-01)

Efficacy and Safety of Rituximab in patients with Neuromyelitis Optica Spectrum Disorders: A prospective observation in Iranian Cases.
by: Maral Seyed Ahadi, et al.
Published: (2020-03-01)

No lack of regulatory B cells in patients with Multiple Sclerosis
by: Michel Laure, et al.
Published: (2012-11-01)

The Burnt City and the Evolution of the Concept of “Probability” In the Human Brain
by: Abdorreza NASER MOGHADASI
Published: (2015-10-01)

First Visual Evidence of Leprosy in the Continental Shelf of Iran
by: Abdorreza NASER-MOGHADASI
Published: (2015-10-01)

Tragedy of rostam and sohrab: first example introducing the science of mytho-pathology.
by: Abdorreza Naser Moghadasi
Published: (2014-08-01)

Artificial Eye in Burnt City and Theoretical Understanding of How Vision Works.
by: Abdorreza Naser Moghadasi
Published: (2014-11-01)

Anahita Arәdvī Sūra: The Goddess of Health
by: Abdorreza Naser Moghadasi
Published: (2015-02-01)

Mithra’s Brain
by: Abdorreza Naser Moghadasi
Published: (2015-08-01)

Comparison of Cytokine Expression in Multiple Sclerosis Patients and Healthy Volunteers
by: Ateke Mousavi Nasl-khameneh, et al.
Published: (2018-02-01)

Cannot write session to /tmp/vufind_sessions/sess_cjui5cvaiu370r5pvfbjjgi89u